文献速递贫血与红细胞疾病

全身铁估算表明19毫克与38毫克口服铁在缓解反复采血者铁缺乏方面等效

Estimates of total body iron indicate 19 mg and 38 mg oral iron are equivalent for the mitigation of iron deficiency in individuals experiencing repeated phlebotomy.
PubMed 文献 · Am J Hematol · 2017-06-09

该两年研究将频繁献血者随机分为不服用药物、安慰剂、19毫克或38毫克葡萄糖酸亚铁组服用60天。重复测量回归分析显示,安慰剂和不服用药物组全身铁每年显著下降52毫克(P=0.001),而19毫克与38毫克铁剂对全身铁的影响无差别(P=0.54)。补铁初期60天后全身铁增加229毫克(P<0.0001),其中红细胞铁增加51毫克(P<0.0001),储存铁增加174毫克(P<0.0001)。

要点

  • 19毫克与38毫克口服铁对献血者全身铁的影响无显著差异(P=0.54)。
  • 不补铁者全身铁每年下降52毫克(P=0.001)。
  • 补铁60天后全身铁增加229毫克,其中储存铁增加174毫克。

核心结论

  • 在献血者中,19毫克与38毫克口服铁对全身铁的影响无差别(P=0.54)。
  • 作者认为,远低于目前常用剂量的铁剂即可有效治疗铁缺乏性贫血。

研究设计与样本

  • 两年研究,频繁献血者随机接受不服用药物、安慰剂、19毫克或38毫克葡萄糖酸亚铁,服用60天。

主要发现

  • 完成入组和最终访视的不服用药物组和安慰剂组亚组全身铁无变化(P=0.21和P=0.28)。
  • 完整数据集的重复测量回归分析估计安慰剂和不服用药物组全身铁每年显著下降52毫克(P=0.001)。
  • 19毫克与38毫克铁剂对全身铁的影响无法区分(P=0.54)。
  • 补铁初始60天后全身铁增加229毫克(P<0.0001),继续补铁后在每次后续献血后维持该较高水平。
  • 全身铁增加中51毫克归于红细胞铁(P<0.0001),174毫克归于储存铁(P<0.0001);同时使用抗酸剂使储存铁变化负向影响57毫克(P=0.04)。

临床怎么用

  • 作者认为,远低于目前常用剂量的铁剂将有效用于铁缺乏性贫血的临床治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Iron deficiency anemia is a common clinical condition often treated with tablets containing 65 mg of elemental iron. Such doses can elicit gastrointestinal side effects lowering patient compliance. Oral iron supplements also increase hepcidin production causing decreased fractional absorption of subsequent doses. Frequent blood donors often become iron deficient. Therefore, they were enrolled in a two-year study involving continued blood donations and randomization to receive no pill, placebo, 19, or 38 mg ferrous gluconate for 60 days. Total body iron (TBI) did not change for the subset of donors in the no pill and placebo groups who completed both enrollment and final visits (P = .21 and P = .28, respectively). However, repeated measures regression analysis on the complete dataset estimated a significant decrease in TBI of 52 mg/year for the placebo and no pill groups (P = .001). The effects of 19 and 38 mg iron supplementation on TBI were indistinguishable (P = .54). TBI increased by 229 mg after the initial 60 days of iron supplementation (P < .0001) and was maintained at this higher level with continued iron supplementation following each subsequent donation. The TBI increase was apportioned 51 mg to red cell iron (P < .0001) and 174 mg to storage iron (P < .0001). Changes in storage iron were negatively impacted by 57 mg due to concurrent antacid use (P = .04). These findings in blood donors suggest that much lower doses of iron than are currently used will be effective for clinical treatment of iron deficiency anemia.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Bialkowski W, Kiss JE, Wright DJ, et al. Estimates of total body iron indicate 19 mg and 38 mg oral iron are equivalent for the mitigation of iron deficiency in individuals experiencing repeated phlebotomy. Am J Hematol. 2017. PMID: 28494509. doi:10.1002/ajh.24784

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。